GTP Bioways will be attending the Antibody Engineering & Therapeutics in Amsterdam from the 6th to the 8th of June 2023.
This event is Europe’s leading antibody conference for accelerating next-generation antibodies to commercial success. The programme is very rich with keynote sessions and scientific briefing from expert scientists. During the course of the three days, many topics on antibodies will be addressed: optimization for affinity, active biotherapeutics, agonist antibodies, immunocytokines, immunotherapy, T-Cell engagers, ADCs, the Fc region, bispecifics… a very high-level agenda!
If you are looking for a human sized CDMO to bring your project into clinical development, this is the perfect occasion to meet with us.
Mélusine Larivière, business Development Manager, and Céline Mathieu-Demazière, Project Designer at GTP Bioways, will welcome you on booth #35 to introduce you to our comprehensive CDMO services. We can manage the process development and GMP manufacturing of any kind of antibodies (monoclonal antibodies, bispecific antibodies, antibody-drug conjugate…). Don’t hesitate to connect with them if you wish to have more information.
Antibody Engineering & Therapeutics
Contact Mrs. Mélusine Larivière, Business Developement Manager, to schedule a meeting.